We’re currently upgrading our membership platform to bring you an improved experience. During this transition, access to member accounts is temporarily unavailable. We appreciate your patience and can’t wait to share the new and improved system with you soon!
For urgent membership questions, please contact info@clpsychiatry.org.
Journal Article Annotations
2025, 3rd Quarter
Annotations by Sneha Jadhav, MD
September, 2025
The finding:
The study found three trajectories of suicidal ideation: Minimal/No Ideation (87.6%), Early Adolescent Onset (7.1%), Young Adult Onset (5.2%). Early-onset group showed elevated disruptive symptoms from childhood onwards. Suicidal ideation was associated with persistent internalizing and externalizing symptoms. There was strong association with maternal antisocial traits. Late-onset group was linked to internalizing symptoms emerging in adolescence and worsening in young adulthood. There was a notable lack of externalizing symptoms in childhood.
Strength and weaknesses:
The study has a Longitudinal design spanning over two decades (ages 3–25) and uses multi- informant data (parents, teachers, self). It used validated measures and survey weighting to account for attrition.
Limitations include use of self-reported suicidal ideation which could lead to underreporting or recall bias. The study did not include clinical diagnoses—symptoms were assessed via questionnaires, not structured interviews. The study is based on a specific population and may have limited generalizability.
Relevance:
Disruptive behaviors in childhood are often secondary to poor impulse control which plays an important role in mood regulation and suicidal ideation/ comments at that age. This may be an important factor in adult presentation as well and may have limited response to anti- depressants. History of such traits may help alter the treatment protocols early on to include therapy or medication directed at impulse regulation. Early-onset may require more intensive, multimodal interventions due to chronicity and comorbidity. Late-onset may benefit from targeted treatment of emerging internalizing symptoms.
Maternal psychopathology may be an important risk marker.